A detailed history of Pnc Financial Services Group, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,766 shares of GKOS stock, worth $538,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,766
Previous 4,310 12.62%
Holding current value
$538,312
Previous $510,000 3.92%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$113.62 - $135.39 $61,809 - $73,652
-544 Reduced 12.62%
3,766 $490,000
Q2 2024

Aug 09, 2024

SELL
$89.48 - $118.35 $1,342 - $1,775
-15 Reduced 0.35%
4,310 $510,000
Q1 2024

May 10, 2024

BUY
$76.4 - $96.33 $8,709 - $10,981
114 Added 2.71%
4,325 $407,000
Q4 2023

Feb 09, 2024

SELL
$59.53 - $85.11 $11,965 - $17,107
-201 Reduced 4.56%
4,211 $334,000
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $4,084 - $4,666
59 Added 1.36%
4,412 $332,000
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $9,088 - $14,241
200 Added 4.82%
4,353 $309,000
Q1 2023

May 15, 2023

SELL
$43.88 - $52.48 $8,424 - $10,076
-192 Reduced 4.42%
4,153 $208,000
Q4 2022

Feb 10, 2023

SELL
$40.82 - $57.75 $5,306 - $7,507
-130 Reduced 2.91%
4,345 $189,000
Q3 2022

Nov 10, 2022

BUY
$46.84 - $58.49 $10,117 - $12,633
216 Added 5.07%
4,475 $238,000
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $21,404 - $39,154
-614 Reduced 12.6%
4,259 $193,000
Q1 2022

May 12, 2022

BUY
$44.33 - $57.82 $6,738 - $8,788
152 Added 3.22%
4,873 $281,000
Q4 2021

Feb 11, 2022

SELL
$40.27 - $56.99 $22,792 - $32,256
-566 Reduced 10.71%
4,721 $209,000
Q3 2021

Nov 05, 2021

BUY
$47.43 - $84.23 $7,161 - $12,718
151 Added 2.94%
5,287 $254,000
Q2 2021

Aug 06, 2021

BUY
$73.06 - $97.7 $168,695 - $225,589
2,309 Added 81.68%
5,136 $435,000
Q1 2021

May 07, 2021

BUY
$70.43 - $97.42 $1,056 - $1,461
15 Added 0.53%
2,827 $237,000
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $4,303 - $6,622
88 Added 3.23%
2,812 $211,000
Q3 2020

Nov 06, 2020

SELL
$37.23 - $50.97 $409 - $560
-11 Reduced 0.4%
2,724 $134,000
Q2 2020

Aug 07, 2020

BUY
$28.78 - $46.83 $39,284 - $63,922
1,365 Added 99.64%
2,735 $105,000
Q1 2020

May 08, 2020

BUY
$25.53 - $70.14 $30,610 - $84,097
1,199 Added 701.17%
1,370 $42,000
Q4 2019

Feb 07, 2020

SELL
$54.18 - $65.64 $2,329 - $2,822
-43 Reduced 20.09%
171 $9,000
Q3 2019

Nov 08, 2019

BUY
$58.58 - $83.91 $5,799 - $8,307
99 Added 86.09%
214 $13,000
Q2 2019

Aug 09, 2019

BUY
$63.59 - $78.71 $6,041 - $7,477
95 Added 475.0%
115 $0
Q2 2018

Aug 10, 2018

BUY
$27.62 - $44.51 $552 - $890
20 New
20 $0
Q4 2017

Feb 09, 2018

SELL
$24.5 - $36.01 $1.88 Million - $2.77 Million
-76,804 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$31.26 - $42.03 $2.4 Million - $3.23 Million
76,804
76,804 $0

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.8B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.